Hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population

Biomarkers in Medicine

Volumn 8, Issue 2, 2014, Pages 259-267

  Omrani, Mohsen ^a,b   Hashemi, Mohammad ^a,b   Eskandari Nasab, Ebrahim ^b   Hasani, Seyed Shahaboddin ^b   Mashhadi, Mohammad Ali ^b   Arbabi, Farshid ^b   Taheri, Mohsen ^c  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

breast cancer; hsa mir 146a; hsa mir 196a2; hsa mir 499; microRNAs; miRNAs

Indexed keywords

ADULT; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; IRAN; MICRORNAS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84894339166     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.13.118     Document Type: Article

References (50)

1. Hashemi M, Eskandari-Nasab E, Fazaeli A et al. Association between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian population. Biomarkers Med. 6(6), 797-803 (2012).
2. Eskandari-Nasab E, Hashemi M, Rezaei H et al. Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer. Mol. Biol. Rep. 39(12), 10531-10539 (2012).
3. Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA. miRNAs and related polymorphisms in rheumatoid arthritis susceptibility. Autoimmun. Rev. 11, 639-641 (2012).
4. Hashemi M, Eskandari-Nasab E, Zakeri Z et al. Association of pre-miRNA-146a rs2910164 and premiRNA-499 rs3746444 polymorphisms and susceptibility to rheumatoid arthritis. Mol. Med. Rep. 7(1), 287-291 (2012).
5. Hua Z, Chun W, Fang-Yuan C. MicroRNA-146a and hemopoietic disorders. Int. J. Hematol. 94(3), 224-229 (2011).
6. Yu J, Li A, Hong SM, Hruban RH, Goggins M. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin. Cancer Res. 18(4), 981-992 (2012).
7. Wang Y, Li Z, He C et al. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Mol. Dis. 44(3), 191-197 (2010).
8. Shin KC, Choi EY, Chung JH, Jeon C, Lee KH. Clinical application of MAGE A1-6 RT-nested PCR for diagnosis of lung cancer invisible by bronchoscopy. Anticancer Res. 32(1), 163-167 (2012).
9. Hu Z, Liang J, Wang Z et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum. Mutat. 30(1), 79-84 (2009).
10. Wang Y, Yang B, Ren X. Hsa-miR-499 polymorphism (rs3746444) and cancer risk: a meta-Analysis of 17 case-control studies. Gene 509(2), 267-272 (2012).
11. Wang L, Qian S, Zhi H, Zhang Y, Wang B, Lu Z. The association between hsa-miR-499 T>C polymorphism and cancer risk: a meta-Analysis. Gene 508(1), 9-14 (2012).
12. Zhao S, Liu Y, Zhang Q et al. The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-Analysis of published literature. Breast Cancer Res. Treat. 130(3), 809-816 (2011).
13. Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA. Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem. Soc. Trans. 36(Pt 6), 1211-1215 (2008).
14. Garcia AI, Cox DG, Barjhoux L et al. The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Hum. Mutat. 32(9), 1004-1007 (2011).
15. Tanic M, Zajac M, Gomez-Lopez G, Benitez J, Martinez-Delgado B. Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFkappaB pathway. Breast Cancer Res. Treat. 134(1), 41-51 (2011).
16. Matei MC, Negura L, Liliac L, Negura A, Azoicai D. Validation of PCR-RFLP techniques for the evaluation of codon 72 of p53 and CYP1A1 genes polymorphisms in relation with ovarian cancer in a Romanian population. Rom. J. Morphol. Embryol. 53(1), 47-54 (2012).
17. Christoffersen NR, Shalgi R, Frankel LB et al. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ. 17(2), 236-245 (2010).
18. Jegg AM, Ward TM, Iorns E et al. PI3K independent activation of mTORC1 as a target in lapatinib-resistant ERBB2+ breast cancer cells. Breast Cancer Res. Treat. 136(3), 683-692 (2012).
19. De La Chapelle A, Jazdzewski K. MicroRNAs in thyroid cancer. J. Clin. Endocrinol. Metab. 96(11), 3326-3336 (2011).
20. Liu Z, Li G, Wei S et al. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116(20), 4753-4760 (2010).
21. Catucci I, Yang R, Verderio P et al. Evaluation of SNPs in miR-146a, miR196a2 and miR- 499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum. Mutat. 31(1), e1052-e1057 (2010).
22. Xiang Y, Fan S, Cao J, Huang S, Zhang LP. Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol. Biol. Rep. 39(6), 7019-7023 (2012).
23. Yang L, Li Y, Cheng M et al. A functional polymorphism at microRNA-629-binding site in the 3-untranslated region of NBS1 gene confers an increased risk of lung cancer in southern and eastern Chinese population. Carcinogenesis 33(2), 338-347 (2012).
24. Mittal RD, Gangwar R, George GP, Mittal T, Kapoor R. Investigative role of pre-microRNAs in bladder cancer patients: a case-control study in north India. DNA Cell Biol. 30(6), 401-406 (2011).
25. Lian H, Wang L, Zhang J. Increased risk of breast cancer associated with CC genotype of Has-miR-146a rs2910164 polymorphism in Europeans. PLoS ONE 7(2), e31615 (2012).
26. Pastrello C, Polesel J, Della Puppa L, Viel A, Maestro R. Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/ BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis 31(12), 2124-2126 (2010).
27. Zhi H, Wang L, Ma G et al. Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease. Clin. Res. Cardiol. 101(4), 289-296 (2011).
28. Xiang Y, Fan S, Cao J, Huang S, Zhang LP. Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol. Biol. Rep. 39(6), 7019-7023 (2012).
29. Gao LB, Bai P, Pan XM et al. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-Analysis. Breast Cancer Res. Treat. 125(2), 571-574 (2011).
30. Hashemi M, Moazeni-Roodi AK, Fazaeli A et al. Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran. Genet. Mol. Res. 9(1), 333-339 (2010).
31. Hashemi M, Moazeni-Roodi A, Bahari A, Taheri M. A tetra-primer amplification refractory mutation system-polymerase chain reaction for the detection of rs8099917 IL28B genotype. Nucleosides Nucleotides Nucleic Acids 31(1), 55-60 (2012).
32. Hashemi M, Hoseini H, Yaghmaei P et al. Association of polymorphisms in glutamate-cysteine ligase catalytic subunit and microsomal triglyceride transfer protein genes with nonalcoholic fatty liver disease. DNA Cell Biol. 30(8), 569-575 (2011).
33. Li L, Chen XP, Li YJ. MicroRNA-146a and human disease. Scand. J. Immunol. 71(4), 227-231 (2010).
34. Li J, Wan Y, Guo Q et al. Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res. Ther. 12(3), R81 (2010).
35. Wang F, Sun G, Zou Y, Li Y, Hao L, Pan F. Association of microRNA-499 rs3746444 polymorphism with cancer risk: evidence from 7188 cases and 8548 controls. PLoS ONE 7(9), e45042 (2012).
36. Wang J, Wang Q, Liu H et al. The association of miR-146a rs2910164 and miR- 196a2 rs11614913 polymorphisms with cancer risk: a meta-Analysis of 32 studies. Mutagenesis 27(6), 779-788 (2012).
37. Xu W, Xu J, Liu S et al. Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-Analysis. PLoS ONE 6(5), e20471 (2011).
38. Wang J, Bi J, Liu X, Li K, Di J, Wang B. Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-Analysis of 19 case-control studies. Mol. Biol. Rep. 39(4), 4571-4579 (2012).
39. Qiu LX, He J, Wang MY et al. The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine 56(3), 695-698 (2011).
40. Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 29(10), 1963-1966 (2008).
41. Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA. miRNAs and related polymorphisms in rheumatoid arthritis susceptibility. Autoimmun. Rev. 11(9), 636-641 (2012).
42. Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res. Ther. 10(4), R101 (2008).
43. Nahid MA, Satoh M, Chan EK. MicroRNA in TLR signaling and endotoxin tolerance. Cell. Mol. Immunol. 8(5), 388-403 (2011).
44. Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA. The role of microRNA-146a (miR-146a) and its target IL-1R-Associated kinase (IRAK1) in psoriatic arthritis susceptibility. Scand. J. Immunol. 71(5), 382-385 (2010).
45. Boldin MP, Taganov KD, Rao DS et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208(6), 1189-1201 (2011).
46. Wang AX, Xu B, Tong N et al. Meta-Analysis confirms that a common G/C variant in the pre-miR-146a gene contributes to cancer susceptibility and that ethnicity, gender and smoking status are risk factors. Genet. Mol. Res. 11(3), 3051-3062 (2012).
47. Landgraf P, Rusu M, Sheridan R et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129(7), 1401-1414 (2007).
48. Desjardins S, Beauparlant JC, Labrie Y, Ouellette G, Durocher F. Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer. BMC Cancer 9, 181 (2009).
49. Pickard MR, Green AR, Ellis IO et al. Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer. Breast Cancer Res. 11(4), R60 (2009).
50. Alshatwi AA, Shafi G, Hasan TN et al. Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PLoS ONE 7(2), e30049 (2012).